US Patent 8039005 Mutant forms of streptolysin O
Patent 8039005 was granted and assigned to Novartis on October, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+222 characters)
Article
Patent abstract
Forms of GAS25 (streptolysin O) which are not toxic but which still maintain the ability to induce protection against S. pyogenes are useful in vaccine compositions to induce protection against S. pyogenes.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Emiliano Chiarot0
Giuliano Bensi0
Guido Grandi0
Immaculada Margarit Y Ros0
Maria Scarselli0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08039005 Mutant forms of streptolysin O US Patent 8039005 Mutant forms of streptolysin O
Infobox
Patent Number
080390050
Patent Number
80390050
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080390050
Date of Patent
October 18, 2011
0Patent Application Number
127118690
Date Filed
February 24, 2010
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08039005 Mutant forms of streptolysin O
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08039005
Date of patent
October 18, 2011
Patent application number
12711869
Date Filed
February 24, 2010
Patent primary examiner
Find more entities like US Patent 8039005 Mutant forms of streptolysin O
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.